Nyheter/rapporter

Senaste pressmeddelanden och rapporter för bevakat bolag.

Datum Källa Rubrik Typ Alternativ
2024-02-01 Penser Access by Carnegie Penser Access by Carnegie: Arcoma Group - 4 minutes by Penser Pressreleaser Visa Stäng
2024-01-30 Penser Access by Carnegie Penser Access by Carnegie: Intervju med Arcoma - Carnegie Investment Bank - 30 jan 2024 Pressreleaser Visa Stäng
2024-01-30 Penser Access by Carnegie Penser Access by Carnegie: Arcoma - Rekordstarkt Q4 skapar starkt momentum in i 2024 Pressreleaser Visa Stäng
2024-01-29 Arcoma Bokslutskommuniké 2023 – REKORDSTARKT KVARTAL, NETTOOMSÄTTNINGEN ÖKAR MED 24%, EBITDA ÖKAR MED 134% (MAR) Pressreleaser Visa Stäng
2024-01-25 Arcoma Arcoma AB tidigarelägger publicering av delårsrapport för oktober-december 2023 Pressreleaser Visa Stäng
2023-12-20 Arcoma Arcoma välkomnar ny ägarstruktur efter Sunstone Life Science Ventures försäljning av aktier Pressreleaser Visa Stäng
2023-11-30 Arcoma Arcoma byter likviditetsgarant och Certified Adviser till Carnegie Investment Bank AB (publ) Pressreleaser Visa Stäng
2023-11-17 Arcoma Valberedning utsedd inför årsstämma 2024 i Arcoma AB Pressreleaser Visa Stäng
2023-10-27 Penser Access Penser Access: Tillväxt och marginal i Q3 understryker skalbarhet - Acroma Pressreleaser Visa Stäng
2023-10-26 Penser Access Penser Access: Intervju med Arcoma - Erik Penser Bank - 26 oktober 2023 Pressreleaser Visa Stäng
2023-10-26 Arcoma Kvartalsrapport Q3 2023 – Stark tillväxt och lönsamhet – Nettoomsättningen ökar med 24%, EBITDA ökar med 37% (MAR) Pressreleaser Visa Stäng
2023-08-18 Penser Access Penser Access: God tillväxt i normaliserat marknadsklimat - Arcoma Pressreleaser Visa Stäng
2023-08-17 Arcoma Kvartalsrapport Q2 2023 – Fortsatt tillväxt – Omsättningen ökar med 24% (MAR) Pressreleaser Visa Stäng
2023-07-05 Arcoma Tarik Cengiz utses till ny Global Sales Director och Jesper Lindroos blir ny COO. Pressreleaser Visa Stäng
2023-06-12 Arcoma Arcoma signs distribution agreement with Canon Korea Inc. Pressreleaser Visa Stäng
2023-05-17 Arcoma Kommuniké från årsstämma i Arcoma Aktiebolag den 17 maj 2023. Pressreleaser Visa Stäng
2023-05-03 Arcoma Arcoma AB has received certification according to MDR (MAR) Pressreleaser Visa Stäng
Pressreleaser | 3 May 2023 | Arcoma

Arcoma AB has received certification according to MDR (MAR)

2023-05-03

PRESSRELEASE

Arcoma AB has received certification according to MDR (MAR)

We are proud to announce that Arcoma AB has received certification according to MDR (regulation EU 2017/745). Arcoma’s product range of Precision i5 and Intuition are therefore fully compatible with the EU regulations for medical devices.

The new EU regulations MDR, Medical Device Regulation, which began to be applied in 2021, is a comprehensive change to the regulations for medical devices. The requirement for MDR certification guarantees that the medical devices used in healthcare are safe.

”Certification according to the MDR is an incredibly important milestone for us, it is proof that our products are safe and live up to the high standards required for medical equipment. The certification is very important for us as a company, for our customers and not least for the patients’ safety”, says Henrik Blomdahl, Quality Manager Arcoma AB.

”I am really happy that the certification has gone through and would like to thank everyone in the organization led by Henrik who have contributed to this success,” says Mattias Leire, CEO Arcoma AB

About Arcoma

Arcoma, with long experience in the industry, is a leading provider of integrated digital X-ray systems with high quality and advanced technology. Arcoma’s products offer the latest digital imaging technology combined with technically advanced moving positioning systems and ergonomic Scandinavian design. Arcoma offers the customers complete, configurable and functional digital x-ray systems. The company’s products are sold through retailers as well as OEM customers and today there are over 3,500 of Arcoma’s X-ray systems installed worldwide. Arcoma is listed on Nasdaq First North. For more information about Arcoma, please visit www.arcoma.se

For more information, please contact:

Henrik Blomdahl, Manager Quality and Regulatory, henrik.blomdahl@arcoma.se , +46 470-706922.
Mattias Leire, VD, mattias.leire@arcoma.se , +46 766-66 54 88
The information was submitted, through the CEO, for publication on May 3rd, 2023 at 10.20 PM.

For more IR-related information and the possibility of pressrelease prenumeration, please visit our IR page: www.arcoma.se/about-us/investors/

This information is such information that Arcoma AB is obliged to publish in accordance with the EU Market Abuse Regulation (MAR). The information was submitted, through the CEO, for publication on May 3rd , 2023 at 10.20 PM.


2023-05-03 Arcoma Arcoma AB har erhållit certifiering enligt MDR (MAR) Pressreleaser Visa Stäng
2023-05-03 Penser Access Penser Access: Intervju med Arcoma - Erik Penser Bank - 3 maj 2023 Pressreleaser Visa Stäng
2023-05-02 Penser Access Penser Access: Förlänger trend av stark tillväxt - Arcoma Pressreleaser Visa Stäng
2023-04-27 Arcoma Kvartalsrapport Q1 2023: Positivt momentum – nettoomsättningen ökar med 55% (MAR) Pressreleaser Visa Stäng
2023-04-26 Arcoma Arcoma receives order of 10 systems to Thailand Pressreleaser Visa Stäng
2023-04-13 Arcoma Kallelse till årsstämma i Arcoma Aktiebolag Pressreleaser Visa Stäng
2023-04-06 Arcoma Årsredovisning 2022 är nu publicerad Pressreleaser Visa Stäng

Kommande händelser

25 Apr 2024 | Kvartalsrapport 2024-Q1
17 May 2024 | Årligutdelning
15 Aug 2024 | Kvartalsrapport 2024-Q2
24 Oct 2024 | Kvartalsrapport 2024-Q3